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Introduction
Sepsis and septic shock still represent major health
issues, with persisting high morbidity and mortality
rates in critically ill patients. Cardiac dysfunction [1]
occurs frequently during severe sepsis.
Adrenomedullin (ADM) has been identified as a key
mediator in vascular tone regulation[1]. A newly devel-
oped anti-ADM antibody Adrecizumab (ADZ) may
improve hemodynamic dysfunction during resuscitated
murine, cecal ligation and puncture (CLP)-induced sep-
tic shock [2].
Objectives
To determine the beneficial role of ADZ on hemody-
namic impairment in a rat model of acute sepsis.
Methods
For induction of polymicrobial sepsis, cecal ligation and
puncture (CLP) [3] was performed in Wistar male rats.
ADZ (2 mg/kg) was injected IV 24 h after the surgery.
There were 7 animals per group. Invasive blood pressure
and cardiac function (by echocardiography) were
assessed until 2 hours after ADZ injection. Statistical
analysis was performed with 2 ways ANOVA.
Results
Septic rats had lower mean arterial pressure (MAP) (p <
0.0001) 24 h after surgery (at baseline) compared to
sham. Septic animas with ADZ had a trend to have a
greater MAP. A transient decrease of SF was observed
15 min and 1 h after injection of ADZ (p = 0.05). On
the other hand cardiac output seems to be increased by
ADZ (p = 0.61).
Conclusions
During sepsis in rats, treatment by ADZ seems to have a
beneficial effect on cardiac and vascular dysfunction.
These preliminary results need to be confirmed in pre-
clinical and clinical studies.
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